Prof. Tao Liu 刘涛
Chief Physician, Professor
Department of Digestive Oncology Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and laparoscopic treatment of gastrointestinal malignancies, including gastric, colorectal, and hepatobiliary-pancreatic tumors. Focuses on standardized surgical and endoscopic management of pancreatic cancer, cholangiocarcinoma, and ampullary carcinoma.
Dr. Liu holds an MD and PhD. With 20 years of clinical experience, Dr. Liu serves as Director of the Digestive Tumor Surgery Department at Union Hospital. Dr. Liu studied at Harvard Medical School and MD Anderson Cancer Center for three years, focusing on molecular target screening for targeted therapy. Current research includes translational medicine for colorectal cancer targeted therapy and molecular mechanisms of pancreatic cancer.
Professional roles
- Vice Chair, Youth Committee of Pancreatic Cancer Professional Committee, China Anti-Cancer Association
- Member, Tumor Surgery Branch, Chinese Research Hospital Association
- Standing Committee Member, Hubei Clinical Oncology Society
- Corresponding Editor, Chinese Journal of Experimental Surgery
Name order: in Chinese the family name comes first (Liu Tao). Papers usually list the name as Tao Liu or Liu T.
Selected publications
111 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Discov Oncol, 2026 (senior author): Prognostic implications and precision selection criteria of primary tumor resection in metastatic gallbladder adenocarcinoma. PubMed 42678493
- Transl Cancer Res, 2026 (senior author): A novel prognostic model for colon adenocarcinoma based on cofactor and vitamin metabolism-related genes. PubMed 41674972
- BMC Cancer, 2025 (senior author): Lymphovascular invasion affects prognosis of colorectal cancer liver metastasis underwent primary resection: a propensity score matching analysis. PubMed 40296050
- Sci Rep, 2025 (senior author): Author Correction: Oxidative stress index-based scoring for prediction of long-term prognosis in patients with colorectal cancer with liver metastases. PubMed 40169721
- Sci Rep, 2025 (senior author): Oxidative stress index-based scoring for prediction of long-term prognosis in patients with colorectal cancer with liver metastases. PubMed 39939349
- Sci Rep, 2024 (senior author): Unveiling shared therapeutic targets and pathological pathways between coronary artery disease and major depressive disorder through bioinformatics analysis. PubMed 39592804
- iScience, 2024 (senior author): RRM2 promotes liver metastasis of pancreatic cancer by stabilizing YBX1 and activating the TGF-beta pathway. PubMed 39398252
- Cancer Gene Ther, 2024 (senior author): ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation. PubMed 39069526
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion